RUBRACA (rucaparib camsylate)
EPITHELIAL OVARIAN CANCER WITH BRCA MUTATION ·+1
CLOVIS ONCOLOGY
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
ZEJULA (niraparib tosylate)
EPITHELIAL OVARIAN CANCER WITH BRCA MUTATION ·+1
TESARO, INC.
LYNPARZA (olaparib)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · EPITHELIAL OVARIAN CANCER ·+5
AstraZeneca Pharmaceuticals
ZEJULA (niraparib tosylate)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · EPITHELIAL OVARIAN CANCER WITH BRCA MUTATION ·+1
GSK
RUBRACA (rucaparib camsylate)
EPITHELIAL OVARIAN CANCER WITH BRCA MUTATION ·+1
CLOVIS/PHARMAAN
RUBRACA (rucaparib camsylate)
ANTINEOPLASTIC-POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR · EPITHELIAL OVARIAN CANCER WITH BRCA MUTATION ·+1
ZR PHARMA& GMBH